Dutch company engineering organ-on-a-chip microchips for drug development.
| Date | Round | Amount |
|---|---|---|
| Mar 2022 | Funding round Delft organ-on-a-chip biotech Bi/ond raised 4M dollars led by FORWARD.one to advance its microchip platform for drug development. | $3.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.